First-pass extracted concept

very early recurrence

Candidate: concept label1 source documents8 linked claims
Live refresh every 5sNext refresh in 5s

Aliases

VER

Evidence Snippets

the most sever outcome is very early recurrence (VER), which occurs within 12 weeks
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1clinical implicationsupports2026Source 1DOIPubMed

Identifying patients with grade 3 tumors, pancreatic head tumors, or elevated red cell distribution width may support tailored intensive surveillance and consideration of early adjuvant therapy.

Claim 2definitionsupports2026Source 1DOIPubMed

Very early recurrence in pancreatic ductal adenocarcinoma is defined here as recurrence within 12 weeks after curative-intent surgery.

Claim 3frequencysupports2026Source 1DOIPubMed

Approximately 50% of patients experience recurrence within one year after curative-intent surgery for pancreatic ductal adenocarcinoma.

Claim 4method performancesupports2026Source 1DOIPubMed

Random forest modelling increased predictive accuracy for very early recurrence by identifying nonlinear patterns in the data.

Claim 5outcome associationsupports2026Source 1DOIPubMed

Very early recurrence is associated with higher six-month mortality than later recurrence in the discussed pancreatic cancer setting.

Claim 6predictor associationsupports2026Source 1DOIPubMed

Abnormal red cell distribution width is identified as a risk factor for very early recurrence.

Claim 7predictor associationsupports2026Source 1DOIPubMed

Pancreatic head tumor location is associated with very early recurrence.

Claim 8predictor associationsupports2026Source 1DOIPubMed

Poorly differentiated grade 3 tumor is highlighted as the strongest predictor of very early recurrence.